Which HPLC Method Development, Validation, and Analysis do we offer?
HPLC Method Development, Validation, and Analysis by NorthEast BioLab
NorthEast BioLab provides HPLC method development, validation, and Analysis services for various stages – from early discovery to clinicaldevelopment phase.
During the drug discovery phase, our expert scientists collaborate to select and optimize the HPLC method that would be utilized for your analysis. HPLC methods help analyze drug concentration in biological fluids to evaluate ADME (absorption, distribution, metabolism, and excretion) profile of the drug. The drug discovery phase also involves pharmacology and toxicology assessments of the drug compounds.
HPLC method development and validation are essential in this phase as the preclinical studies aim to generate and document the safety, pharmacokinetics, toxicokinetics, and potency parameters for the drug compounds.
Upon successful IND filing, the clinical phase of drug development is initiated and the HPLC method developed completed earlier is further refined for the analysis of drugs and metabolites in biofluids as per the pharmacokinetic studies.